Insilico Medicine, a biotech startup based in Hong Kong and New York, has unveiled a groundbreaking achievement in the field of drug discovery. In a new paper published in Nature Biotechnology, the company showcases what it claims to be the first AI-generated and AI-discovered drug, now advancing to Phase II clinical trials. INS018_055: Targets Rare … Continue reading Insilico Medicine Unveils First-Ever Drug Discovered and Designed by Artificial Intelligence